Parsons Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4.64M | Buy |
|
|||||
2025
Q1 | $3.77M | Buy |
|
|||||
2024
Q4 | $2.83M | Buy |
|
|||||
2024
Q3 | $2.56M | Buy |
|
|||||
2024
Q2 | $2.47M | Buy |
|
|||||
2024
Q1 | $1.12M | Buy |
|
|||||
2023
Q4 | $320K | Buy |
|
|||||
2023
Q3 | $239K | Hold |
|
|||||
2023
Q2 | $242K | Sell |
|
|||||
2023
Q1 | $217K | Buy |
|
|||||
2021
Q4 | – | Sell |
|
|||||
2021
Q3 | $230K | Sell |
|
|||||
2021
Q2 | $542K | Sell |
|
|||||
2021
Q1 | $733K | Sell |
|
|||||
2020
Q4 | $1.43M | Sell |
|
|||||
2020
Q3 | $1.66M | Buy |
|
|||||
2020
Q2 | $1.65M | Buy |
|
|||||
2020
Q1 | $1.27M | Buy |
|